Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold

Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold

Submitted by admin on August 30, 2022 - 11:50am
Source: 
Endpoints
News Tags: 
Beam Therapeutics
FDA
CAR-T
Headline: 
Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold
snippet: 

Last month, Beam Therapeutics revealed the FDA intended to place its preclinical off-the-shelf CAR-T therapy on hold. Today, the company revealed the reasons why.

Do Not Allow Advertisers to Use My Personal information